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Background: Previous experimental studies have shown that vitamin C has several
beneficial effects in sepsis and burns, such as decreased tissue oedema, improved
endothelial barrier function and decreased transcapillary leakage of plasma markers.
It has still not been investigated, though, if vitamin C has any impact specifically on
plasma volume. The present study aims at testing the hypothesis that vitamin C
decreases plasma volume loss in sepsis.
Methods: Anaesthetized male adult Sprague-Dawley rats were used in this prospective
randomized study. All experiments were carried out at a university hospital laboratory.
Sepsis was induced by caecal ligation and incision. After 3 h, vitamin C was given either
as a bolus dose (66 mg/kg) followed by a continuous infusion (33 mg/kg/h) (n = 9),
or as a single bolus dose (200 mg/kg) (n = 9). A sham group (n = 9) underwent the
same surgical procedure, but no vitamin C was given. Plasma volume was measured
(125I-dilution technique) at baseline, at 3 h after end of initiation of sepsis and at the
end of the experiment 3 h later. Arterial blood samples for analyses of electrolytes,
blood gases, haematocrit and lactate were taken at the same time points.
Results: There were no significant differences in plasma volumes or the
physiological parameters analysed between any of the three groups at any time
point. There was a significantly larger urine production in the single bolus dose
group (200 mg/kg) compared to the sham group.
Conclusions: Vitamin C treatment did not decrease the loss of plasma volume in
the septic rat. The diuretic effect of vitamin C was in accordance with previous
studies.
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Caecal ligationBackground
Vitamin C has been shown to have beneficial effects on the microcirculation in moder-
ate sepsis in the rat [1,2]. On a consensus meeting on vitamin C in acute endothelial
pathophysiological conditions in 2006, it was concluded that there were arguments
based on experimental studies for the hypothesis that high-dose vitamin C improves
microvascular endothelial function in sepsis [3]. This hypothesis was further supported
by some recent studies in septic mice. Thus, Fisher et al. showed that vitamin C has
positive effects on various pathophysiological changes in sepsis, including the micro-
vasculature of the lung [4,5], and Zhou et al. showed that vitamin C decreases capillary
leakage of different injected tracers [6].2014 Bark and Grände; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
ttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any
edium, provided the original work is properly credited.
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also beneficial in burns by preventing capillary leakage, lymph flow and resuscitation
fluid requirements [7-9]. In a more recent study, vitamin C treatment was shown to re-
duce the endothelial damage caused by transfusion of plasma from a burned donor rat
[10]. Further, a human study showed a reduction in resuscitation volume with vitamin
C treatment after severe burn [11]. In contrast, Aliabadi-Wahle et al. found no changes
in microvascular permeability or in oedema formation when vitamin C was given after
burn in the dog [12].
Even though not fully understood, suggested mechanisms behind the described bene-
ficial effects of intravenous vitamin C treatment, in both sepsis and burns, are scaven-
ging of reactive oxygen species, reduction of endothelial adhesion molecules and
modulation of nitric oxide production [3,13-15].
Sepsis, as well as burns, causes transcapillary leakage of plasma, reducing the circulat-
ing plasma volume [16,17]. As discussed above, experimental studies have shown that
vitamin C reduces local oedema and leakage of plasma markers. However, these find-
ings do not necessarily reflect a decrease in plasma volume loss, and so far, no study
has specifically investigated the effect of vitamin C treatment on plasma volume. In the
present study, we therefore tested the hypothesis that vitamin C would reduce the loss
of plasma volume in the early stage of sepsis. Treatment was initiated 3 h after induc-
tion of sepsis, a more clinically relevant time point than used in most studies found in
the current literature, where treatment was started either before or closely after injury
(e.g. sepsis, burns). Different dose regimes have been used in previous studies. Benefi-
cial effects on microcirculation have been shown with low-dose treatment [1,2], but it
seems that higher doses are needed to counteract microvascular leakage. We chose to
compare two different treatment regimes, both previously shown to be effective to pre-
vent capillary leakage - one with a small bolus dose followed by a continuous infusion
[9,10] and one with a high bolus dose as single treatment [4,6]. A sham group that
underwent the same surgical procedure, but received no treatment, was also included
in the study.Methods
Anaesthesia and set-up
The study was approved by the Ethical Committee for Animal Research at Lund
University, Sweden (application no. M180-10). The animals were treated in accordance
with the guidelines of the National Institutes of Health for Care and Use of Laboratory
Animals. Male adult Sprague-Dawley rats were used, weighing 337 ± 26 g (mean ± SD).
Anaesthesia was induced using a covered glass container with a continuous supply of
5% isoflurane in air (Forene® 100%; Abbot Scandinavia AB, Solna, Sweden), in which
the animals were placed. After induction, the animals were removed from the con-
tainer, and anaesthesia was maintained with 1.5% to 1.8% isoflurane in air using a mask,
while tracheostomy was performed. Thereafter, the animals were connected to a venti-
lator (Ugo Basile; Biological Research Apparatus, Comerio, Italy) and ventilated in
a volume-controlled mode with a positive end expiratory pressure of 4 cm H2O.
End-tidal PCO2 was continuously monitored (Capstar-100; CWE, Ardmore, PA, USA).
Anaesthesia was maintained with 1.5% to 1.8% isoflurane in air throughout the
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feedback-controlled heating pad. The left femoral artery was cannulated to monitor
arterial blood pressure and to obtain blood samples for analysis of electrolytes, haem-
atocrit, lactate, arterial blood gases (I-STAT; Abbot Point of Care Inc, Abbot Park, IL,
USA) and plasma volumes. The left femoral vein was cannulated and used for infu-
sions, and kept open with a continuous infusion of saline at 0.2 μL/min. The right
internal jugular vein was cannulated and used for injection of 125I-albumin for plasma
volume measurements. At the end of the experiments, the animals were sacrificed with
an intravenous injection of potassium chloride.Experimental procedure
A well-established rat model of severe sepsis was used [16,18]. A longitudinal midline
skin incision in the abdominal wall with diathermia was performed, followed by lapar-
otomy by incision along the linea alba. After ligation just below the ileocaecal valve, an
incision of 1 cm in length was made in the caecum, allowing leakage of faeces into the
abdominal cavity, thereby inducing sepsis/systemic inflammatory response syndrome
(SIRS). The abdominal wall and the skin were then closed with clips. There was no
bleeding during the experiment.Plasma volume
Plasma volume (PV) was determined with a reliable and established technique, shown
to produce reproducible and reliable results [16,19-21]. As described previously [16],
PV was determined by measuring the radioactivity in 100 μL of plasma taken 5 min
after an intravenous injection of human 125I-albumin (0.5 mL) with a known amount of
activity. The increase in radioactivity was calculated by subtracting the activity in a
blood sample taken just before the injection from that taken 5 min after the injection,
thereby adjusting for any remaining radioactivity from previous measurements. To cal-
culate the amount of radioactivity given, the remaining activity in the emptied vial, syr-
inge and needle used was measured and subtracted from the total activity in the
prepared dose. Sources of error are small with the technique used. Free iodine was
measured regularly following precipitation with 10% trichloroacetic acid and was found
to be less than 2.0% in the prepared samples. Radioactivity was measured with a
gamma counter (Wizard 1480; LKB-Wallac, Turku, Finland).Experimental protocol
In this study, we evaluated the effect of intravenous vitamin C on plasma volume in
the early stage of sepsis in the rat. The septic rats were divided into three groups: a
bolus + infusion group (the B + I group, n = 9), a bolus group (the B group, n = 9) and a
sham group (the S group, n = 9). Animals that did not show a decrease in PV 3 h after
the preparation were considered to be non-septic and were excluded from the study.
These animals and animals that died before the end of the experiment were replaced
with new animals.
After cannulation and surgical preparation, the animals were left undisturbed for 3 h,
a time period previously shown to be sufficient for systemic inflammation and plasma
leakage to develop [16]. Three hours after surgical preparation, the treatment was
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dro-L-threo-hexono-1,4-lactone, Askorbinsyra 100 mg/ml, APL, Stockholm, Sweden)
of 66 mg/kg, followed by an infusion of 33 mg/kg/h during the rest of the experiment
(Figure 1). In previous studies, this dose regime has been shown to be effective in decreas-
ing microvascular permeability after burns in the rat [9,10]. The B group received a single
intravenous bolus injection of 200 mg/kg of ascorbic acid (Figure 1), previously shown to
be effective in septic mice [4,6]. The S group received no treatment, as it was meant to
represent a non-treatment situation.
Plasma volumes were measured at baseline, at 3 h after the end of surgical prepar-
ation and at the end of the experiment another 3 h later. Blood samples for measure-
ment of arterial pH, PCO2, PO2, lactate, haematocrit, sodium and potassium were
taken at the same time points.
Urine was collected in a glass vial placed at the external meatus of the urethra
throughout the whole experiment, and the bladder was emptied by external compres-
sion at the end of the experiment.Statistical analysis
Statistical analyses were performed with GraphPad Prism software version 5.0c for Mac
OS X (GraphPad Software, San Diego, CA, USA). Physiological data and plasma volumes
were compared using two-way ANOVA for repeated measures followed by Bonferroni
post hoc test and unpaired two-tailed Student's t test. Urine productions were compared
using unpaired two-tailed Student's t test. Differences were considered significant when
p < 0.05. To achieve a statistical power of 90% with a difference in PV (PV3 − PV2) be-
tween groups of 4 mL/kg, the calculated sample size for each group was 9. All data were
normally distributed. The results are presented as mean ± SD.Results
Five animals died before the end of the experiment, evenly distributed between the
groups. Eleven animals were considered to be non-septic and were excluded from the
study, as they did not show a decrease in PV 3 h after the preparation.Figure 1 Time scale of the experiment. PV1, plasma volume at baseline; PV2, plasma volume 3 h after
surgical preparation just before the start of treatment; PV3, plasma volume at the end of the experiment;
ABG, arterial blood sample for analysis of blood gases, hematocrit, lactate and electrolytes.
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Data for sodium (Na+), potassium (K+), haematocrit (Hct), lactate (Lac), pH, PaCO2 and
PaO2, from arterial blood samples taken at baseline, at 3 h after the end of surgical prepar-
ation and at the end of the experiment 3 h later are summarized in Table 1. Data for arter-
ial blood pressure are presented in Table 2. There were no significant differences between
the groups in blood pressure or any of the parameters analysed at any time point. There
was a significant increase in potassium and lactate levels, and a decrease in pH and PaCO2
in all groups at the end of the experiments compared to baseline (Table 1).Plasma volume
Plasma volumes at baseline, at 3 h after the end of the surgical preparation and at the
end of the experiment 3 h later were 41.2 ± 1.7 mL/kg, 35.2 ± 2.4 mL/kg and 27.4 ± 3.6
in the B + I group; 43.9 ± 3.1 mL/kg, 37.8 ± 3.3 mL/kg and 28.0 ± 5.0 mL/kg in the B
group; and 42.4 ± 1.0 mL/kg, 35.9 ± 2.0 mL/kg, and 29.6 ± 2.4 mL/kg in the S group
(Figure 2). There were no significant differences in PV between the three groups at any
time point. There was a significant reduction in plasma volume in all three groups 3 h
after the end of the surgical preparation (PV2) compared to baseline (PV1), and at the
end of the experiment (PV3) compared to 3 h after the end of the surgical preparation
(PV2) (p < 0.01) (Figure 2).Urine production
Urine production from the end of surgical preparation to the end of the experiment
was 6.9 ± 3.4 mL/kg in the B + I group, 8.5 ± 1.4 mL/kg in the B group and 4.7 ± 1.8
mL/kg in the S group. The urine production was significantly larger in the B group







pH PaCo2 (kPa) PaO2 (kPa)
Bolus + infusion group
(n = 9)
Baseline 136 ± 2 4.9 ± 0.3 42 ± 1 2.4 ± 0.3 7.48 ± 0.04 4.9 ± 0.4 11.0 ± 0.8
3 h after prep 133 ± 3 5.3 ± 0.6 45 ± 3 2.7 ± 0.4 7.44 ± 0.03 4.9 ± 0.5 10.8 ± 0.7
End of experiment 135 ± 2 6.2 ± 0.8*** 50 ± 5** 3.2 ± 0.7** 7.43 ± 0.04* 4.2 ± 0.4** 11.4 ± 0.5
Bolus group (n = 9)
Baseline 137 ± 2 4.4 ± 0.3 42 ± 3 2.3 ± 0.5 7.48 ± 0.03 5.0 ± 0.4 11.1 ± 0.6
3 h after prep 133 ± 2 5.2 ± 0.3 45 ± 3 2.9 ± 0.5 7.44 ± 0.02 4.9 ± 0.4 11.4 ± 0.5
End of experiment 135 ± 2 5.8 ± 0.9*** 50 ± 4*** 3.4 ± 0.8** 7.43 ± 0.04** 3.7 ± 0.7*** 12.5 ± 1.3
Sham group (n = 9)
Baseline 136 ± 2 4.8 ± 0.6 43 ± 2 2.3 ± 0.2 7.48 ± 0.05 4.9 ± 0.5 11.0 ± 0.9
3 h after prep 134 ± 2 5.1 ± 0.6 45 ± 1 2.6 ± 0.3 7.45 ± 0.03 4.8 ± 0.3 11.0 ± 1.0
End of experiment 134 ± 2 5.9 ± 0.6** 49 ± 2*** 2.9 ± 0.7* 7.44 ± 0.03* 4.1 ± 0.3*** 12.0 ± 0.7
Data (mean ± SD) for sodium (Na+), potassium (K+), haematocrit (Hct), lactate (Lac), pH, arterial partial pressure of carbon
dioxide (PaCO2) and arterial partial pressure of oxygen (PaO2). There were no significant differences between any of the
parameters analysed, between groups at any time points. Two-way ANOVA for repeated measures followed by Bonferroni
post hoc test was used for the statistical analyses. There were significant differences in K+, Hct, Lac, pH and Paco2 between
baseline and the end of the experiments in all groups. Unpaired two-tailed Student's t test was used for the analyses.
*p < 0.05, **p < 0.01, ***p < 0.001.
Table 2 Blood pressure
Baseline 3 h after
surg prep
1.5 h after start
of treatment
3 h after start
of treatment
Bolus + infusion group
(n = 9)
96 ± 11 92 ± 12 99 ± 14 96 ± 13
Bolus group (n = 9) 88 ± 15 91 ± 12 92 ± 16 90 ± 13
Sham group (n = 9) 95 ± 12 90 ± 11 94 ± 7 93 ± 7
Data (mean ± SD) for mean arterial blood pressure (mmHg) at baseline, at 3 h after the surgical preparation and at 1.5
and 3 h after the start of treatment. There were no differences between any of the groups at any time points. Two-way
ANOVA for repeated measures followed by Bonferroni post hoc test was used for the statistical analyses.
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The two investigated treatment regimes of vitamin C had no effect on plasma volume
loss or any of the physiological parameters analysed in the early stage of sepsis in the
present study in the rat. The larger urine production in the B group was in accordance
with previous studies, both in humans and in dogs, showing a diuretic effect of vitamin
C [22,23]. It has been suggested [23] that this effect is due to an increase in glomerular
filtration, although the exact mechanism of action is unclear. However, as urine repre-
sents loss of fluid from the entire extracellular space, meaning that only 20% to 25% of
the volume is lost from the PV, the larger urine production in the B group will only
have had a minor effect on the PV (0.8 to 1.0 mL/kg). A previous study on anaesthe-
tised rats with artificial ventilation has shown that perspiration during this time period
has no effect on plasma volume [24]. This means that the plasma volume loss in the
present study must represent tissue oedema.
The higher potassium concentrations and lower PaCO2 and pH at the end of the
experiments in all groups are compatible with sepsis/SIRS-induced cell destruction,
increased lactate production and subsequent compensatory hyperventilation (Table 1).
The 125I-dilution technique for measurement of plasma volume is well established
and reliable with small potential errors as described in detail previously [16,19-21].
There might have been overestimation of plasma volume because of transcapillary es-
cape of radioactive albumin during the 5-min period between injection of the tracer
and collection of the blood sample. However, errors will have no or minor influence on


































Figure 2 Plasma volumes. Plasma volumes at baseline (PV1), at 3 h after the surgical preparation just
before the start of treatment (PV2) and at the end of the experiment (PV3). There was no significant difference
between any of the groups at any time points. There was a significant difference between PV1 and PV2, and PV2
and PV3 for all groups. Two-way ANOVA for repeated measures followed by Bonferroni post hoc test was used
































Figure 3 Urine production. Data for urine production (mL/kg) from the end of surgical preparation to the
end of the experiment. There was a significantly larger urine production in the B group compared to the S
group. Student's t test was used for the statistical analyses (***p < 0.001).
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leakage by an increase in capillary pressure. This increase, however, must have been of
the same magnitude in all groups and will therefore have no influence on the conclu-
sions made.
While previous studies have shown beneficial effects of vitamin C, such as reduced
transcapillary leakage, reduced lymph flow and reduced oedema formation, using the
same treatment regimes that were used in the present study [4,6,9,10], we could not
demonstrate any effects on the plasma volume loss.
As mentioned in the ‘Background’, in most of the experimental studies listed above
showing beneficial effects of vitamin C, treatment was initiated either prior to injury
or shortly thereafter. The fact that we started the treatment 3 h after injury might
explain our negative results. Our negative results may also be partly explained by the
fact that caecal ligation and incision used in the present study probably resulted in a more
severe sepsis than in the caecal ligation and puncture model used in many other studies.
We also chose to evaluate the effect on plasma volumes 3 h after initiation of treatment, a
time period shorter than in most other previous studies, and it cannot be excluded that
this might have contributed to our negative results. In one study [6], treatment with vita-
min C (200 mg/kg) was initiated 3 h after injury, as in the present study, and they demon-
strated a positive effect, in terms of reduced capillary leakage of Evans blue after 12 h in
the septic mouse. This study was performed in rats, and our results might therefore not
be directly transferred to man. For example, in contrast to man, rats are able to synthesize
vitamin C.Conclusions
In conclusion, the present study did not confirm our hypothesis, as intravenous vitamin
C treatment initiated 3 h after induction of sepsis had no effect on the loss of plasma
volume, or any of the physiological parameters analysed, in the early stage of sepsis in
the rat. High-dose vitamin C caused an increase in urine production.
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